116 related articles for article (PubMed ID: 34856473)
1. A novel regulatory mechanism of geniposide for improving glucose homeostasis mediated by circulating RBP4.
Liu J; Song C; Nie C; Sun Y; Wang Y; Xue L; Fan M; Qian H; Wang L; Li Y
Phytomedicine; 2022 Jan; 95():153862. PubMed ID: 34856473
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4.
Liu J; Nie C; Xue L; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Wang L; Li Y
Theranostics; 2021; 11(17):8283-8300. PubMed ID: 34373742
[No Abstract] [Full Text] [Related]
3. The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.
Chiefari E; Paonessa F; Iiritano S; Le Pera I; Palmieri D; Brunetti G; Lupo A; Colantuoni V; Foti D; Gulletta E; De Sarro G; Fusco A; Brunetti A
BMC Biol; 2009 May; 7():24. PubMed ID: 19460132
[TBL] [Abstract][Full Text] [Related]
4. Liver-secreted RBP4 does not impair glucose homeostasis in mice.
Fedders R; Muenzner M; Weber P; Sommerfeld M; Knauer M; Kedziora S; Kast N; Heidenreich S; Raila J; Weger S; Henze A; Schupp M
J Biol Chem; 2018 Sep; 293(39):15269-15276. PubMed ID: 30126844
[TBL] [Abstract][Full Text] [Related]
5. Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice.
Tan Y; Sun LQ; Kamal MA; Wang X; Seale JP; Qu X
Biochim Biophys Acta; 2011 Dec; 1811(12):1045-53. PubMed ID: 21983273
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin.
Gokulakrishnan K; Pandey GK; Sathishkumar C; Sundararajan S; Durairaj P; Manickam N; Mohan V; Balasubramanyam M
Mol Biol Rep; 2021 May; 48(5):4093-4106. PubMed ID: 34041677
[TBL] [Abstract][Full Text] [Related]
7. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
8. Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.
Zemany L; Bhanot S; Peroni OD; Murray SF; Moraes-Vieira PM; Castoldi A; Manchem P; Guo S; Monia BP; Kahn BB
Diabetes; 2015 May; 64(5):1603-14. PubMed ID: 25524914
[TBL] [Abstract][Full Text] [Related]
9. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
Bahr MJ; Boeker KH; Manns MP; Tietge UJ
Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
[TBL] [Abstract][Full Text] [Related]
10. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
11. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
[TBL] [Abstract][Full Text] [Related]
12. Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus.
Chen Y; Lv P; Du M; Liang Z; Zhou M; Chen D
Arch Gynecol Obstet; 2017 Jul; 296(1):53-61. PubMed ID: 28528355
[TBL] [Abstract][Full Text] [Related]
13. Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance.
Moraes-Vieira PM; Castoldi A; Aryal P; Wellenstein K; Peroni OD; Kahn BB
Diabetes; 2016 May; 65(5):1317-27. PubMed ID: 26936962
[TBL] [Abstract][Full Text] [Related]
14. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
15. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
16. RBP4 Is Associated With Insulin Resistance in Hyperuricemia-Induced Rats and Patients With Hyperuricemia.
Liu C; Zhou XR; Ye MY; Xu XQ; Zhang YW; Liu H; Huang XZ
Front Endocrinol (Lausanne); 2021; 12():653819. PubMed ID: 34177800
[TBL] [Abstract][Full Text] [Related]
17. RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice.
Ma X; Zhou Z; Chen Y; Wu Y; Liu Y
Diabetologia; 2016 Feb; 59(2):354-62. PubMed ID: 26564180
[TBL] [Abstract][Full Text] [Related]
18. Rac1 muscle knockout exacerbates the detrimental effect of high-fat diet on insulin-stimulated muscle glucose uptake independently of Akt.
Raun SH; Ali M; Kjøbsted R; Møller LLV; Federspiel MA; Richter EA; Jensen TE; Sylow L
J Physiol; 2018 Jun; 596(12):2283-2299. PubMed ID: 29749029
[TBL] [Abstract][Full Text] [Related]
19. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model.
Trajcevski KE; O'Neill HM; Wang DC; Thomas MM; Al-Sajee D; Steinberg GR; Ceddia RB; Hawke TJ
PLoS One; 2013; 8(8):e71747. PubMed ID: 23951235
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
Koh IU; Jun HS; Choi JS; Lim JH; Kim WH; Yoon JB; Song J
Biol Pharm Bull; 2012; 35(3):369-75. PubMed ID: 22382323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
